Volume 2, Issue 3 And 4 (11-2015)                   vacres 2015, 2(3 And 4): 63-68 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shafaati M, Akhavan E, Yazdani S, Shafaati M. Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism. vacres 2015; 2 (3 and 4) :63-68
URL: http://vacres.pasteur.ac.ir/article-1-68-en.html
Department of Cellular & Molecular Biology IAU, Hamadan Branch, Hamadan, Iran.
Abstract:   (6003 Views)

Introduction: In recent years, influenza viruses have caused moderate to severe infections all around the world while so far there is no influenza vaccine that can protect people with only one dose of injection. In this regard, producing a universal vaccine based on virus-like-particles (VLP) could be an ideal approach.  Methods: In this study, the full-length ORF of influenza hemagglutinin (HA) gene from Influenza A virus of H9N2 subtype was amplified by RT-PCR using specific primers to produce HA cDNA. The amplicon was cloned firstly into a T/A cloning vector and then was subcloned into a pFastBacDual donor plasmid through SalI/HindIII restriction sites.  The recombinant HA-pFastBacDual vector was transferred to Escherichia coli DH10Bac cells, to insert the HA gene into the bacmid DNA via a site-specific transposition process. The recombinant bacmid was then extracted and further analyzed by PCR.  Results: Our data indicated that the HA-containing recombinant bacmid was constructed successfully using the transposition mechanism between pFastBacDual-HA and the bacmid. Conclusion: The recombinant baculovirus construct in this work had proper characteristics to be used in production of H9N2 VLP in Sf9 insect cell line in the future studies.

Full-Text [PDF 816 kb]   (2902 Downloads)    
Type of Study: Original article |
Received: 2016/03/8

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.